Tricyclic Antidepressants May Slow Liver Fibrosis Progression, Cirrhosis - Monthly Prescribing Reference (registration)

Tricyclic Antidepressants May Slow Liver Fibrosis Progression, CirrhosisMonthly Prescribing Reference (registration)BOSTON, MA—Use of tricyclic antidepressants (TCAs) is associated with decreased liver fibrosis progression and delayed time to cirrhosis development, according to a large cohort of veterans with hepatitis C virus (HCV), presented at The Liver Meeting® ...